Armistice Capital »

New Residential Investment shares owned by Armistice Capital

Quarter-by-quarter ownership of New Residential Investment (RITM) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in New Residential Investment

Tip: Access up to 7 years of quarterly data

All positions including New Residential Investment held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in New Residential Investment by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $464k 49k 9.48

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding New Residential Investment

BlackRock
Vanguard Group
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Wellington Management Company
Geode Capital Management
Charles Schwab Investment Management
Bank of America Corporation
Morgan Stanley
Qube Research & Technologies
LSV Asset Management
UBS Group
Goldman Sachs Group
Northern Trust

View all funds holding New Residential Investment